8-K: CDT Equity Inc. Issues Pre-Funded Warrants for Sarborg Stake

CDT Equity Inc. has entered into a Securities Purchase Agreement to acquire a 4.76% stake in Sarborg Limited by issuing pre-funded warrants.

Summary

• CDT Equity Inc. has acquired 270 shares of Sarborg Limited, representing approximately 4.76% of Sarborg's outstanding common stock.
• The acquisition was made through a Securities Purchase Agreement dated July 30, 2026.
• In exchange for the Sarborg shares, CDT Equity Inc. issued pre-funded warrants to purchase up to 12,131,770 shares of its common stock.
• These pre-funded warrants have a nominal exercise price of $0.0001 per share and require shareholder approval for the issuance of underlying shares exceeding 19.99% of outstanding stock.
• The company has committed to filing a resale registration statement within 60 days of closing.
• Additionally, CDT Equity Inc. issued 123,537 shares of common stock to service providers on July 30th and July 31st, 2026, under exemptions from registration.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral development. While the acquisition of a stake in Sarborg is a strategic move, the significant potential dilution from the pre-funded warrants and the reliance on shareholder approval introduce uncertainty.

Positives

• Acquisition of a strategic stake (4.76%) in Sarborg Limited.
• Issuance of pre-funded warrants allows for future equity participation in CDT Equity Inc.
• Agreement to file a resale registration statement facilitates potential liquidity for investors.
• The transaction was structured to comply with securities law exemptions (Section 4(a)(2) and Rule 506).

Negatives

• The issuance of pre-funded warrants is contingent on shareholder approval, which may not be obtained.
• The potential issuance of up to 12,131,770 shares could lead to significant dilution if exercised.
• The transaction involves related party interests, with a director and CEO also being a director and stockholder of Sarborg through his investment company.

Risks

• Failure to obtain shareholder approval for the issuance of Pre-Funded Warrant Shares could prevent the full exercise of warrants.
• The significant number of potential shares issuable upon exercise of the warrants could lead to substantial dilution for existing shareholders.
• The securities issued are subject to resale restrictions under federal and state securities laws until registered or an exemption is available.
• The company's reliance on exemptions from registration means that the securities may not be freely tradable.

Future Outlook

The company is obligated to use commercially reasonable efforts to file a resale registration statement within 60 days of the closing of the Purchase Agreement. The exercise of the pre-funded warrants is subject to shareholder approval, which is required for issuances exceeding 19.99% of outstanding common stock or voting power.

Management Comments

• Andrew Regan, a director and the Chief Executive Officer of the Company, is a director of Sarborg and a stockholder of Sarborg through his wholly-owned investment company Corvus Capital Limited (Corvus).
• Corvus participated in the transaction contemplated by the Purchase Agreement and received Pre-Funded Warrants to purchase 5,436,830 Pre-Funded Warrant Shares in exchange for Sarborg shares.
• Dr. Regan did not receive consideration in excess of that being provided to other Investors.
• Chele Farley and Ulrik Olsen are directors of the Company and stockholders of Sarborg; but did not participate in the transactions, did not receive any Securities and will not receive any consideration from the transactions contemplated by the Purchase Agreement.

Industry Context

StockSavvy.ai notes that this transaction reflects a common strategy for companies seeking to acquire strategic assets or stakes in other entities, often utilizing warrant structures to defer immediate equity dilution while securing future capital or control. The reliance on exemptions and the need for shareholder approval are standard considerations in such deals.

Related Party Transactions

• Andrew Regan, CEO and director of CDT Equity Inc., is also a director and stockholder of Sarborg Limited through his investment company, Corvus Capital Limited. Corvus participated in the transaction and received pre-funded warrants.

Stakeholder Impact

• Shareholders: Potential for significant dilution if pre-funded warrants are exercised, impacting ownership percentage and potentially share value. Shareholder approval is required for large issuances.
• Investors (Sarborg Shareholders): Receive pre-funded warrants in CDT Equity Inc., providing an opportunity to participate in the company's future equity, subject to registration and approval.
• Service Providers: Received shares of common stock as compensation for services rendered.

Next Steps

• CDT Equity Inc. must use commercially reasonable efforts to file a resale registration statement within 60 days of the closing.
• The company needs to obtain shareholder approval for the issuance of Pre-Funded Warrant Shares if the aggregate issuance exceeds 19.99% of outstanding stock.
• Investors may exercise their pre-funded warrants, subject to the above conditions.

Key Dates

Recommendation

The filing details a strategic acquisition and the issuance of warrants, which introduces potential future dilution. The outcome is contingent on shareholder approval and the company's ability to register the shares for resale. Without more financial performance data or a clearer path to value realization from the Sarborg stake, a 'hold' recommendation is prudent.

Keywords

Pre-funded Warrants, Securities Purchase Agreement, Sarborg Limited, CDT Equity Inc., Equity Acquisition, Stockholder Approval, Dilution, Registration Statement